Literature DB >> 22503049

Protective effects of hydrogen rich saline solution on experimental testicular ischemia-reperfusion injury in rats.

Dapeng Jiang1, Dongzhen Wu, Yubo Zhang, Bo Xu, Xuejun Sun, Zhaozhu Li.   

Abstract

PURPOSE: We examined the effectiveness of hydrogen rich saline solution on the prevention of testicular damage induced by ischemia/reperfusion in rats.
MATERIALS AND METHODS: Male Sprague-Dawley® rats were divided randomly into 4 groups, including group 1-sham operated, group 2-torsion-detorsion, group 3-torsion-detorsion plus saline and group 4-torsion-detorsion plus hydrogen rich saline solution. Testicular torsion was performed by rotating the left testis 720 degrees clockwise for 4 hours. Reperfusion was allowed for 4 hours. Hydrogen rich saline solution (5 ml/kg) was injected intraperitoneally in rats in group 4 15 minutes before the start of detorsion. Rats were sacrificed after 4-hour initiation of detorsion. Left orchiectomy was done for histopathological examination and biochemical assay.
RESULTS: The testicular injury score in groups 2 and 3 was significantly lower than in sham operated group 1 but higher in group 4 with hydrogen rich saline than in group 2 with torsion-detorsion. The apoptosis index was significantly increased in groups 2 and 3. Hydrogen rich saline solution treatment significantly decreased the apoptosis index. A significant increase in malondialdehyde and a decrease in superoxide dismutase activity were observed in groups 2 and 3. In group 4 malondialdehyde was significantly lowered and superoxide dismutase activity was significantly improved compared with groups 2 and 3.
CONCLUSIONS: Results provide a biochemical and histopathological basis for the action of hydrogen rich saline solution as a therapeutic agent for testicular damage induced by ischemia/reperfusion injury.
Copyright © 2012 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22503049     DOI: 10.1016/j.juro.2012.01.029

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  8 in total

1.  Basic research: Rat studies untwist roles of protective agents in testicular ischaemia-reperfusion injury.

Authors:  Annette Fenner
Journal:  Nat Rev Urol       Date:  2012-05-08       Impact factor: 14.432

2.  Beneficial biological effects and the underlying mechanisms of molecular hydrogen - comprehensive review of 321 original articles.

Authors:  Masatoshi Ichihara; Sayaka Sobue; Mikako Ito; Masafumi Ito; Masaaki Hirayama; Kinji Ohno
Journal:  Med Gas Res       Date:  2015-10-19

3.  Hydrogen-rich saline attenuates spinal cord hemisection-induced testicular injury in rats.

Authors:  Li Ge; Li-Hua Wei; Chang-Qing Du; Guo-Hua Song; Ya-Zhuo Xue; Hao-Shen Shi; Ming Yang; Xin-Xin Yin; Run-Ting Li; Xue-Er Wang; Zhen Wang; Wen-Gang Song
Journal:  Oncotarget       Date:  2017-06-27

Review 4.  Molecular hydrogen: a preventive and therapeutic medical gas for various diseases.

Authors:  Li Ge; Ming Yang; Na-Na Yang; Xin-Xin Yin; Wen-Gang Song
Journal:  Oncotarget       Date:  2017-09-21

Review 5.  Antioxidants in experimental ischemia-reperfusion injury of the testis: Where are we heading towards?

Authors:  George Vaos; Nick Zavras
Journal:  World J Methodol       Date:  2017-06-26

Review 6.  Hydrogen Gas: A Novel Type of Antioxidant in Modulating Sexual Organs Homeostasis.

Authors:  Yaxing Zhang; Haimei Liu; Jinwen Xu; Shuhui Zheng; Lequan Zhou
Journal:  Oxid Med Cell Longev       Date:  2021-01-16       Impact factor: 6.543

7.  Proteomic analysis of testicular ischemia-reperfusion injury in rats.

Authors:  In-Ohk Ouh; Min-Goo Seo; Fawad-Ali Shah; Sang-Ah Gim; Phil-Ok Koh
Journal:  J Vet Med Sci       Date:  2013-11-01       Impact factor: 1.267

Review 8.  Hydrogen, a potential safeguard for graft-versus-host disease and graft ischemia-reperfusion injury?

Authors:  Lijuan Yuan; Jianliang Shen
Journal:  Clinics (Sao Paulo)       Date:  2016-09       Impact factor: 2.365

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.